Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer

Repetitive, low-dose (metronomic; METRO) drug administration of some anticancer agents can overcome drug resistance and increase drug efficacy in many cancers, but the mechanisms are not understood fully. Previously, we showed that METRO dosing of topotecan (TOPO) is more effective than conventional...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitra Ghosh, Taraswi, White, Jason, Davis, Joshua, Mazumder, Suman, Kansom, Teeratas, Skarupa, Elena, Barnett, Grafton S., Piazza, Gary A., Bird, R. Curtis, Mitra, Amit K., Yates, Clayton, Cummings, Brian S., Arnold, Robert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685420/
https://www.ncbi.nlm.nih.gov/pubmed/34938177
http://dx.doi.org/10.3389/fphar.2021.736951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685420/
https://www.ncbi.nlm.nih.gov/pubmed/34938177
http://dx.doi.org/10.3389/fphar.2021.736951

Ejemplares similares